Friday, February 1, 2013

• Investors Discounting Positive Data Readout On Brain Cancer Studiesat Seeking Alpha (Fri, Feb 1)

Thursday, January 24, 2013

• Record Levels of Available Cash and Moderate R&D Development Will See Big Pharma M&A Activity Increase in 2013Marketwired (Thu, Jan 24)

Wednesday, January 23, 2013

• 2 Biotech Champions For 2013at Seeking Alpha (Wed, Jan 23)

Tuesday, January 22, 2013

• Volterra Risk/Reward Deemed Favorable and 4 Stock Analyses to Followat Wall St. Cheat Sheet (Tue, Jan 22)

Thursday, January 10, 2013

• Fiserv Reiterated at Outperform and 3 Reiterated Ratings Making Roundsat Wall St. Cheat Sheet (Thu, Jan 10)
• Celldex May Soar in 2013at Motley Fool (Thu, Jan 10)
• Allergan Catalysts Drive Expansion and 4 Stock Analyses to Know Nowat Wall St. Cheat Sheet (Thu, Jan 10)
• Celldex price target raised to $13 from $9 at Cantortheflyonthewall.com (Thu, Jan 10)

Wednesday, January 9, 2013

• Does This Biotech Make the Grade?at Motley Fool (Wed, Jan 9)

Monday, January 7, 2013

• CELLDEX THERAPEUTICS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and ExhibitsEDGAR Online (Mon, Jan 7)

Tuesday, December 25, 2012

• 4 Small Biotech Stocks That Should Continue With Large Returns In 2013.at Seeking Alpha (Tue, Dec 25)

Monday, December 24, 2012

• Biotech Portfolio Update: 2012 Summary And 2013 Outlookat Seeking Alpha (Mon, Dec 24)

Friday, December 21, 2012

• CELLDEX THERAPEUTICS, INC. Files SEC form 8-K, Financial Statements and ExhibitsEDGAR Online (Fri, Dec 21)

Wednesday, December 19, 2012

• 7 Companies Fighting To Cure Cancerat Seeking Alpha (Wed, Dec 19)
• 3 Biotechs Moving Higherat Motley Fool (Wed, Dec 19)

Sunday, December 16, 2012

• 5 of Last Week's Biggest Winnersat Motley Fool (Sun, Dec 16)

Thursday, December 13, 2012

• 2 Biotech Stocks To Consider This Week In The Wake Of Trial Dataat Seeking Alpha (Thu, Dec 13)

Wednesday, December 12, 2012

• Belden Acquires PPC and 4 Stocks Hitting 52-Week Highsat Wall St. Cheat Sheet (Wed, Dec 12)
• 5 Stocks To Watch In Biotechat Seeking Alpha (Wed, Dec 12)

Tuesday, December 11, 2012

• Catalyst Issues Stock to BioMarin, Celldex Reports Positive Results: Healthcare Business Updateat Wall St. Cheat Sheet (Tue, Dec 11)
• 5 Biotechs With Short Squeeze Potential Hitting New 52 Week Highsat Seeking Alpha (Tue, Dec 11)
• Celldex Therapeutics, Inc. Moving Forward With Breast Cancer Treatmentat Seeking Alpha (Tue, Dec 11)
• Stock Watch Tuesday, 11 December 2012at Seeking Alpha (Tue, Dec 11)
• Celldex says CDX-301 well-tolerated in Phase 1 multi-dose studytheflyonthewall.com (Tue, Dec 11)
• Celldex Therapeutics’ CDX-301 Safely Mobilizes Hematopoietic Cells in Phase 1 Study; Future Development PlannedBusiness Wire (Tue, Dec 11)

Add CLDX News to My Yahoo!